Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Operating Margin
Y-mAbs Therapeutics Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | US |
Market Cap | 538.5m USD |
Operating Margin |
-30%
|
Country | US |
Market Cap | 283.9B USD |
Operating Margin |
30%
|
Country | US |
Market Cap | 166.4B USD |
Operating Margin |
24%
|
Country | US |
Market Cap | 108.9B USD |
Operating Margin |
39%
|
Country | US |
Market Cap | 107.3B USD |
Operating Margin |
30%
|
Country | AU |
Market Cap | 134.9B AUD |
Operating Margin |
26%
|
Country | US |
Market Cap | 82.2B USD |
Operating Margin |
32%
|
Country | US |
Market Cap | 44.9B USD |
Operating Margin |
-100%
|
Country | US |
Market Cap | 43.1B USD |
Operating Margin |
-33%
|
Country | US |
Market Cap | 32.3B USD |
Operating Margin |
22%
|
Country | KR |
Market Cap | 40T KRW |
Operating Margin |
30%
|
Profitability Report
View the profitability report to see the full profitability analysis for Y-mAbs Therapeutics Inc.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Y-mAbs Therapeutics Inc's most recent financial statements, the company has Operating Margin of -29.7%.